Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Cardiopoietic stem cell therapy in ischaemic heart failure: long-term clinical outcomes.
Journal: ESC heart failure
Published: July 03, 2020
First-in-Human Use of a Retention-Enhanced Catheter for Endomyocardial Cell Delivery.
Journal: JACC. Cardiovascular interventions
Published: October 18, 2017
Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trials.
Journal: European heart journal
Published: July 14, 2017
Independent academic Data Monitoring Committees for clinical trials in cardiovascular and cardiometabolic diseases.
Journal: European journal of heart failure
Published: December 06, 2016
New medicinal products for chronic heart failure: advances in clinical trial design and efficacy assessment.
Journal: European journal of heart failure
Published: November 18, 2016
Cardiopoietic cell therapy for advanced ischaemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial.
Journal: European heart journal
Published: August 25, 2016
Percutaneous Fluoroscopic-Guided Endomyocardial Delivery in an Experimental Model of Left Ventricular Assist Device Support.
Journal: Journal of cardiovascular translational research
Published: April 21, 2015
Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) trial design.
Journal: European journal of heart failure
Published: March 02, 2015
Multivessel spontaneous coronary artery dissection with angiographic documentation before and after the acute event.
Journal: Coronary artery disease
Published: February 26, 2015
An open-label dose escalation study to evaluate the safety of administration of nonviral stromal cell-derived factor-1 plasmid to treat symptomatic ischemic heart failure.
Journal: Circulation research
Published: February 23, 2013
A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous CD34+ cell administration in patients with refractory angina: design of the RENEW study.
Journal: American heart journal
Published: February 01, 2013
Allogeneic stem cell transplantation for ischemic myocardial dysfunction.
Journal: Current opinion in organ transplantation
Published: November 01, 2012
Last Updated: 09/26/2026